03/19/2025
3:33 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form DEF 14A | |
03/11/2025
3:35 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2025
6:07 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2025
6:08 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
02/06/2025
5:30 PM | NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/04/2025
3:58 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2025
3:58 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
01/23/2025
7:12 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
01/23/2025
7:13 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/22/2025
3:27 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
5:06 PM | NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
| Form SCHEDULE 13G | |
Get the Latest News and Ratings for NBY and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NovaBay Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
01/10/2025
6:03 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2024
6:00 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2024
3:12 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
12/09/2024
6:05 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
11/26/2024
3:08 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
11/22/2024
3:27 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
7:10 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
11/13/2024
4:15 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
11/12/2024
3:52 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
11/08/2024
4:31 PM | Hudson Bay Capital Management LP (Filed by)
NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/06/2024
3:46 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
7:15 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
7:19 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
10/16/2024
3:27 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
3:19 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form DEFM14A | |
09/25/2024
4:17 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form PREM14A | |
09/20/2024
7:08 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
7:08 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
07/29/2024
3:25 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
6:18 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 424B4 | |
07/26/2024
4:19 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form POS EX | |
07/25/2024
11:15 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form EFFECT | |
07/24/2024
7:49 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form S-1/A | |
07/12/2024
5:21 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form S-1/A | |
07/11/2024
7:50 AM | NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
| Form FWP | |
07/11/2024
7:45 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
3:05 PM | NovaBay Pharmaceuticals, Inc. (Subject)
NovaBay Pharmaceuticals (Subject)
| Form FWP | |
07/10/2024
8:30 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form S-1/A | |
06/28/2024
3:21 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 424B3 | |
06/28/2024
2:19 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
Trump’s Secret Weapon (Ad) Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next.
But here's the truth… This is just the beginning.
Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better.
Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times.
Don't wait for the next crash to wipe you out. Act now. Get Your FREE Presidential Transition Guide Today |
06/27/2024
11:15 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form EFFECT | |
06/21/2024
4:26 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
06/20/2024
4:12 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
06/14/2024
7:47 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
6:30 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2024
3:50 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2024
3:43 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K/A | |
05/30/2024
8:24 PM | NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
WU MIJIA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
8:27 PM | NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
Sit Swan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
8:29 PM | Freiman Paul E. (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
8:31 PM | Garlikov Julie (Reporting)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
8:17 PM | NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
Zheng Yongxiang (Reporting)
Zheng Yongxiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
8:22 PM | NovaBay Pharmaceuticals, Inc. (Issuer)
NovaBay Pharmaceuticals (Issuer)
Zheng Yenyou (Reporting)
Zheng Yenyou (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:27 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2024
5:04 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2024
4:21 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2024
8:15 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form ARS | |
04/18/2024
8:00 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form DEF 14A | |
04/18/2024
8:06 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
04/08/2024
3:15 PM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form PRE 14A | |
04/05/2024
11:27 AM | NovaBay Pharmaceuticals, Inc. (Filer)
NovaBay Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
